Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00607802 2017-01-19

Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer

Phase NA Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02639767 2016-12-07

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Phase 1 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02656849 2016-07-01

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

Clinical Trials

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Photoscreening for Retinoblastoma

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers

IMperator

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

SALIENT

REFIT-MSS

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors

Imaging of Advanced Tumours Using [131]I-IAZA

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Absorption and Excretion of Oral Docetaxel

Selinexor Combination Ph 1 Study

89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111

Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma

A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

Yoga for Solid Tumor

Pembrolizumab + Defactinib In Pleural Mesothelioma

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

TSC1/2_SC

RICTOR_SC

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Study of CD133KDEL Toxin in the Treatment for Solid Tumors

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

A Study of PTS for Patients With Solid Tumors

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors